True gynecomastia in congenitally HIV-infected children treated with antiretroviral agents

Journal of Chemotherapy

Volumn 16, Issue 3, 2004, Pages 303-305

  Manfredi, R ^a   Calza, L ^a   Chiodo, F ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Antiretroviral therapy; Congenitally acquired HIV infection; Gynecomastia; Metabolic abnormalities; Prepubertal age; Untoward effects

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; LAMIVUDINE; LOPINAVIR; NELFINAVIR; NUCLEOSIDE ANALOG; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; ZIDOVUDINE;

ANTHROPOMETRY; ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DEVELOPMENTAL STAGE; DUAL ENERGY X RAY ABSORPTIOMETRY; ECHOMAMMOGRAPHY; FOLLOW UP; GLUCOSE BLOOD LEVEL; GONAD FUNCTION; GYNECOMASTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOPHYSIS FUNCTION; LIPOATROPHY; MALE; MONOTHERAPY; PREPUBERTY; SCHOOL CHILD; THYROID FUNCTION; TRIACYLGLYCEROL BLOOD LEVEL; VIRUS LOAD;

EID: 3843063549     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2004.16.3.303     Document Type: Article

References (17)

1. Dehner LP, Hill DA, Deschryver K. Pathology of the breast in children, adolescents, and young adults. Semin Diagn Pathol 1999; 16: 235-47.
2. Ismail AA, Barth JH. Endocrinology of gynecomastia. Ann Clin Biochem 2001; 38: 596-607.
3. Lazala C, Saenger P. Pubertal gynecomastia. J Pediatr Endocrinol Metab 2002; 15: 553-60.
4. Donovan B, Bodsworth NJ, Mulhall BP, Allen D. Gynaecomastia associated with saquinavir therapy. Int J STD AIDS 1999; 10: 49-50.
5. Peyriere H, Mauboussin JM, Rouanet I, et al. Report of gynecomastia in five male patients during antiretroviral therapy for HIV infection. AIDS 1999; 13: 2167-9.
6. Qazi N, Morlese J, King DM, Ahmad R, Nelson M. Diagnosis and management of male breast enlargement in patients with HIV/AIDS. AIDS Read 2000; 10: 703-8.
7. Melbourne KM, Brown SL, Silverblatt FJ. Gynecomastia with stavudine treatment in an HIV-positive patient. Ann Pharmacother 1998; 32: 1108.
8. Manfredi R, Calza L, Chiodo F. Gynecomastia associated with highly active antiretroviral therapy. Ann Pharmacother 2001; 35: 438-9.
9. Mercie P, Viallard JF, Thiebaut R, et al. Efavirenz-associated breast hypertrophy in HIV-infection patients. AIDS 2001; 15: 126-9.
10. Paech V, Lorenzon T, Von Krosigk A, Graefe K, Stoehr A, Plettenberg A. Gynaecomastia in HIV-infected men: association with effects of antiretroviral therapy. AIDS 2002; 16: 1193-5.
11. Pantanowitz L, Evans D, Gross PD, Dezube BJ. HIV-related gynecomastia. Breast J 2003; 9: 131-2.
12. Caso JA, Prieto JM, Casas E, Sanz J. Gynecomastia without lipodystrophy syndrome in HIV-infected men treated with efavirenz. AIDS 2001; 15: 1447-8.
13. Qazi NA, Morlese JF, King DM, Ahmad RS, Gazzard BG, Nelson MR. True gynaecomastia, another manifestation of immune reconstitution disease? Int J STD AIDS 2002; 13: 59-65.
14. Galli M, Gervasoni C, Ridolfo AL, et al. Cytokine production in women with antiretroviral treatment-associated breast fat accumulation and limb wasting. AIDS 2003; 17 (Suppl. 1): S155-61.
15. Piroth L, Grappin M, Petit JM, et al. Incidence of gynecomastia in men infected with HIV and treated with highly active antiretroviral therapy. Scand J Infect Dis 2001; 33: 559-60.
16. McComsey G, Bhumbra N, Ma JF, Rathore M, Alvarez A. Impact of protease inhibitor substitution with efavirenz in HIV-infected children: results of the First Pediatric Switch Study. Pediatrics 2003; 111: e275-81.
17. Collazos J, Ibarra S, Martínez E, Mayo J. Serum prolactin concentrations in patients infected with human immunodeficiency virus. HIV Clin Trials 2002; 3: 133-8.